title: Gene expression profiling of breast cancer cell lines in response to soy isoflavones using a pangenomic microarray approach.
abstract: Although the rate of breast cancer differs between women in Asian and Western countries, molecular genetics/genomics basis of this epidemiological observation remains elusive. Moreover, the intake of phytoestrogens is associated with a lower incidence of breast cancer. Genistein and daidzein are the primary soy isoflavones with a chemical structure similar to estrogens. Conceivably, the actions of phytoestrogens on gene expression signatures might mediate their postulated effects on breast cancer pathogenesis. The present study evaluated the transcriptional responsiveness of breast cancer cells to soy phytoestrogens using a whole-genome microarray-based approach. Human breast cancer cell lines and a fibrocystic breast cell line were treated with genistein or daidzein. We identified 278 and 334 differentially expressed genes after genistein or daidzein treatment, respectively, in estrogen-positive (MCF-7) and estrogen-negative (MDA-MB-231, MCF-10a) cells. Hierarchical clustering of this finding revealed a significant modulation, respectively, of 246 or 169 genes after genistein or daidzein exposures. Importantly, the molecular pathways for the differentially expressed genes included those that relate to cell communication, biodegradation of xenobiotics, lipid metabolism, signal transduction, and cell growth/death. These molecular observations collectively contribute to a growing knowledgebase on the putative mechanism(s) of action of phytoestrogens in breast cancer pathogenesis and chemoprevention.
authors.affiliation: Centre Jean Perrin, Département d'Oncogénétique, Clermont-Ferrand, France.
authors.forename: Samir
authors.initials: S
authors.lastname: Satih
authors.forename: Nasséra
authors.initials: N
authors.lastname: Chalabi
authors.forename: Nadège
authors.initials: N
authors.lastname: Rabiau
authors.forename: Rémy
authors.initials: R
authors.lastname: Bosviel
authors.forename: Luc
authors.initials: L
authors.lastname: Fontana
authors.forename: Yves-Jean
authors.initials: YJ
authors.lastname: Bignon
authors.forename: Dominique J
authors.initials: DJ
authors.lastname: Bernard-Gallon
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics*; D045744:Cell Line, Tumor / Q000187:drug effects*; D002478:Cells, Cultured; D005260:Female; D020869:Gene Expression Profiling / Q000379:methods; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D019833:Genistein / Q000494:pharmacology*; D015894:Genome, Human; D006801:Humans; D007529:Isoflavones / Q000494:pharmacology*; D046228:Microarray Analysis / Q000379:methods*; D008969:Molecular Sequence Data; D005810:Multigene Family; D048789:Phytoestrogens / Q000494:pharmacology*
chemical_list: D007529:Isoflavones; D048789:Phytoestrogens; C004742:daidzein; D019833:Genistein
references.citation: J Natl Cancer Inst. 2006 Sep 20;98(18):1275-84
references.pmid: 16985246
references.citation: Biochim Biophys Acta. 2007 Feb;1769(2):124-30
references.pmid: 17321611
references.citation: Endocr Relat Cancer. 2008 Mar;15(1):161-73
references.pmid: 18310284
references.citation: FEBS Lett. 2005 Mar 14;579(7):1732-40
references.pmid: 15757668
references.citation: J Natl Cancer Inst. 2006 Apr 5;98(7):430-1
references.pmid: 16595771
references.citation: Bioinformatics. 2004 Dec 12;20(18):3705-6
references.pmid: 15297296
references.citation: Oncogene. 2008 Feb 28;27(10):1429-38
references.pmid: 17891184
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
references.pmid: 11309499
references.citation: Nutr Cancer. 2003;45(2):247-55
references.pmid: 12881020
references.citation: Int J Cancer. 1999 May 31;81(5):682-7
references.pmid: 10328216
references.citation: BMC Cancer. 2008 Feb 04;8:41
references.pmid: 18248671
references.citation: Mol Biol Cell. 2008 Sep;19(9):3745-57
references.pmid: 18579687
references.citation: Bioinformatics. 2003 May 1;19(7):825-33
references.pmid: 12724292
references.citation: Rev Epidemiol Sante Publique. 2003 Feb;51(1 Pt 1):3-30
references.pmid: 12684578
references.citation: Mol Cell Biol. 2000 Mar;20(5):1723-32
references.pmid: 10669749
references.citation: Curr Opin Mol Ther. 2007 Dec;9(6):538-44
references.pmid: 18041664
references.citation: Br J Cancer. 2008 Jan 15;98(1):9-14
references.pmid: 18182974
references.citation: Endocr Relat Cancer. 2006 Dec;13(4):995-1015
references.pmid: 17158751
references.citation: Endocr Relat Cancer. 2006 Mar;13(1):169-80
references.pmid: 16601286
references.citation: J Natl Cancer Inst. 2006 Apr 5;98(7):459-71
references.pmid: 16595782
references.citation: Drug Metab Dispos. 2008 Aug;36(8):1594-605
references.pmid: 18480186
references.citation: Breast Cancer Res Treat. 2001 Nov;70(1):47-54
references.pmid: 11767004
references.citation: Pharmacogenomics. 2006 Jul;7(5):663-72
references.pmid: 16886892
references.citation: J Natl Cancer Inst. 1973 Nov;51(5):1409-16
references.pmid: 4357757
references.citation: J Natl Cancer Inst. 1974 Sep;53(3):661-74
references.pmid: 4412247
references.citation: Drug Metab Dispos. 2007 Oct;35(10):1935-41
references.pmid: 17646279
references.citation: Cancer Res. 1990 Sep 15;50(18):6075-86
references.pmid: 1975513
references.citation: Ann Med. 2005;37(6):423-38
references.pmid: 16203615
references.citation: Neoplasia. 2007 Feb;9(2):147-58
references.pmid: 17356711
references.citation: Genome Biol. 2003;4(10):R70
references.pmid: 14519205
references.citation: J Pharmacol Exp Ther. 1999 Jun;289(3):1611-9
references.pmid: 10336559
references.citation: Prostaglandins Other Lipid Mediat. 2007 Nov;84(3-4):116-27
references.pmid: 17991614
references.citation: Thorax. 2005 Jul;60(7):576-81
references.pmid: 15994266
references.citation: Med Hypotheses. 2006;66(6):1093-114
references.pmid: 16513288
references.citation: Endocrinology. 1998 Oct;139(10):4252-63
references.pmid: 9751507
references.citation: Steroids. 2004 Dec;69(13-14):795-801
references.pmid: 15582534
references.citation: Mol Carcinog. 2006 May;45(5):320-32
references.pmid: 16526022
references.citation: Mol Pharmacol. 2001 Sep;60(3):595-602
references.pmid: 11502892
references.citation: Adv Exp Med Biol. 2008;617:625-32
references.pmid: 18497090